311 related articles for article (PubMed ID: 15630669)
1. Role of thrombophilia in deciding on the duration of anticoagulation.
Bauer KA
Semin Thromb Hemost; 2004 Dec; 30(6):633-7. PubMed ID: 15630669
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
3. Management of thrombophilia.
Bauer KA
J Thromb Haemost; 2003 Jul; 1(7):1429-34. PubMed ID: 12871277
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
5. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
Veeger NJ; Piersma-Wichers M; Tijssen JG; Hillege HL; van der Meer J
Br J Haematol; 2005 Feb; 128(4):513-9. PubMed ID: 15686461
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
7. Low intensity warfarin: is it clinically useful in venous thromboembolism management?
Bauer KA
Br J Haematol; 2004 Oct; 127(2):155-8. PubMed ID: 15461620
[TBL] [Abstract][Full Text] [Related]
8. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
[TBL] [Abstract][Full Text] [Related]
9. Should patients with venous thromboembolism be screened for thrombophilia?
Dalen JE
Am J Med; 2008 Jun; 121(6):458-63. PubMed ID: 18501222
[TBL] [Abstract][Full Text] [Related]
10. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
12. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
13. D-dimer, oral anticoagulation, and venous thromboembolism recurrence.
Cosmi B; Palareti G
Semin Vasc Med; 2005 Nov; 5(4):365-70. PubMed ID: 16302157
[TBL] [Abstract][Full Text] [Related]
14. Long-term management of patients after venous thromboembolism.
Kearon C
Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
[TBL] [Abstract][Full Text] [Related]
15. Management options for thrombophilias.
Gallus AS
Semin Thromb Hemost; 2005 Feb; 31(1):118-26. PubMed ID: 15706484
[TBL] [Abstract][Full Text] [Related]
16. Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism.
Wåhlander K; Eriksson H; Lundström T; Billing Clason S; Wall U; Nyström P; Wessman P; Schulman S;
Br J Haematol; 2006 Apr; 133(1):68-77. PubMed ID: 16512831
[TBL] [Abstract][Full Text] [Related]
17. Extended treatment for venous thromboembolism: how long is long enough?
Cosmi B; Palareti G
Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
[TBL] [Abstract][Full Text] [Related]
18. Portal, splenic and mesenteric vein thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
Grouzi E; Politou M; Douramani P; Merkouri E; Gialeraki A; Brountzos H; Perros G; Travlou A
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):722-5. PubMed ID: 19734780
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
20. Outpatient management of anticoagulation therapy.
du Breuil AL; Umland EM
Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
